Advancements in the Treatment of Myeloproliferative Neoplasms and Myelodysplastic Syndromes
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 57
Special Issue Editors
2. Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Interests: hematology; chronic myeloproliferative neoplasms; cardiovascular risk
Special Issues, Collections and Topics in MDPI journals
2. Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Interests: clinical trials
Special Issue Information
Dear Colleagues,
This is an invitation to contribute to a new Special Issue of the Journal of Clinical Medicine (JCM) entitled “Advancements in the Treatment of Myeloproliferative Neoplasms and Myelodysplastic Syndromes”. These complex and heterogeneous myeloid neoplasms usually affect the elderly and are characterized by complex pathophysiological processes including the hematopoietic stem cell and bone marrow microenvironment, chronic inflammatory state, various disease-related debilitating symptoms, high cardiovascular risk, and the intrinsic tendency to transform into more aggressive myeloid entities such as secondary myelofibrosis and acute leukemia. In recent years, significant advances in this field have profoundly affected the diagnostic, prognostic, and therapeutic landscapes. Therefore, the aim of this Special Issue is to give JCM readers an update on the pathophysiology, diagnosis, risk stratification, and the contemporary management of these myeloid neoplasms.
Dr. Ivan Krečak
Dr. Marko Skelin
Dr. Zinaida Perić
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- myeloproliferative neoplasms
- myelodysplastic syndromes
- treatment
- risk stratification
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
